CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-07 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $49.00 | $67K | 102,450 |
| 2021-09-07 | Virgin Herbert EVP, Research & CSO | Sale | −2,750 | $50.00 | $138K | 99,700 |
| 2021-09-07 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −4,125 | 263,255 | ||
| 2021-09-01 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $1.53 | $8K | 114,277 |
| 2021-09-01 | Pang Phillip Chief Medical Officer | Sale | −1,888 | $48.72 | $92K | 112,389 |
| 2021-09-01 | Pang Phillip Chief Medical Officer | Sale | −1,005 | $49.40 | $50K | 111,384 |
| 2021-09-01 | Pang Phillip Chief Medical Officer | Sale | −2,107 | $50.43 | $106K | 109,277 |
| 2021-09-01 | Pang Phillip Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −5,000 | 77,591 | ||
| 2021-08-30 | Napolitano Janet Director | Option exercise | +1,435 | $41.64 | $60K | 4,809 |
| 2021-08-30 | Napolitano Janet Director | Sale | −1,435 | $51.15 | $73K | 3,374 |
| 2021-08-30 | Napolitano Janet Director | Option exercise · Stock Option (Right to Buy) | +1,435 | 31,565 | ||
| 2021-08-25 | Virgin Herbert EVP, Research & CSO | Option exercise | +2,750 | $1.53 | $4K | 102,450 |
| 2021-08-25 | Virgin Herbert EVP, Research & CSO | Sale | −2,750 | $50.00 | $138K | 99,700 |
| 2021-08-25 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −2,750 | 267,380 | ||
| 2021-08-24 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 101,075 |
| 2021-08-24 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $48.00 | $66K | 99,700 |
| 2021-08-24 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 270,130 | ||
| 2021-08-23 | Rice Steven J. Chief Administrative Officer | Option exercise | +10,000 | $12.76 | $128K | 30,000 |
| 2021-08-23 | Rice Steven J. Chief Administrative Officer | Sale | −10,000 | $50.00 | $500K | 20,000 |
| 2021-08-23 | Rice Steven J. Chief Administrative Officer | Option exercise · Employee Stock Option (Right to Buy) | −10,000 | 434,441 |
Page 36 of 54 · 1,063 trades